www.techcrunch.com
DeepScribe, an AI-powered medical transcription platform, has raised $30 million in series A funding led by Nina Achadjian at Index Ventures, with participation from Scale.ai CEO Alex Wang, Figma CEO Dylan Field, and existing investors Bee Partners, Stage 2 Capital and 1984 Ventures. The company’s latest round of funding follows its $5.2 million seed round announced in May 2021. DeepScribe was founded in 2017 by Akilesh Bapu, Matthew Ko and Kairui Zeng with the aim of unburdening doctors from tedious data entry and allowing them to focus on their patients.
